Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Positive pharmacokinetic effect of azathioprine co-medication on infliximab trough levels is dose-dependent.
Dig Liver Dis. 2019 Aug;51(8):1112-1116. doi: 10.1016/j.dld.2019.05.001. Epub 2019 May 28.
Dig Liver Dis. 2019.
PMID: 31147215
Ovarian Reserve Assessed by the Anti-Mullerian Hormone and Reproductive Health Parameters in Women With Crohn´s Disease, a Case-Control Study.
Koller T, Kollerová J, Hlavatý T, Kadlečková B, Payer J.
Koller T, et al. Among authors: kadleckova b.
Physiol Res. 2021 Nov 30;70(Suppl 1):S69-S78. doi: 10.33549/physiolres.934776.
Physiol Res. 2021.
PMID: 34918531
Free PMC article.
Item in Clipboard
Ovarian Reserve Assessed by the Anti-Mullerian Hormone and Reproductive Health Parameters in Women With Crohn´s Disease, a Case-Control Study.
Koller T, Kollerová J, Hlavatý T, Kadlečková B, Payer J.
Koller T, et al. Among authors: kadleckova b.
Physiol Res. 2021 Nov 30;70(Suppl 1):S69-S78.
Physiol Res. 2021.
PMID: 35503052
Free article.
Item in Clipboard
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG; LAUREL Study Group.
Vermeire S, et al.
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798037
Clinical Trial.
Item in Clipboard
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
Danese S, Vermeire S, D'Haens G, Panés J, Dignass A, Magro F, Nazar M, Le Bars M, Lahaye M, Ni L, Bravata I, Lavie F, Daperno M, Lukáš M, Armuzzi A, Löwenberg M, Gaya DR, Peyrin-Biroulet L; STARDUST study group.
Danese S, et al.
Lancet Gastroenterol Hepatol. 2022 Apr;7(4):294-306. doi: 10.1016/S2468-1253(21)00474-X. Epub 2022 Feb 1.
Lancet Gastroenterol Hepatol. 2022.
PMID: 35120656
Clinical Trial.
Item in Clipboard
Cite
Cite